INTRODUCTION: The heterotrimeric G protein alpha-subunit G(s)alpha links receptors to stimulation of cAMP/protein kinase A signaling, which inhibits skin fibroblast proliferation and collagen synthesis. We now describe the development of fibrous tumors in mice with heterozygous disruption of the Gnas gene, which encodes G(s)alpha and other gene products. METHODS AND RESULTS: Disruption of Gnas exon 2 on either the maternal or paternal allele (Gnas(E2-/+)) results in fibromas or angiofibromas on the ears, paws and tail beginning at 4 months of age. The tumors were composed of fibroblastic cell proliferation with collagen and elastin deposition and calcification, and seemed to be associated with mechanical skin damage. The presence of calcification was associated with greater amounts of matrix metalloproteinase-2, suggesting an association between calcium deposition and extracellular matrix degradation. Osteoblast-specific markers were absent, consistent with the calcification not being secondary to ossification. Molecular studies showed that the tumors were not associated with deletion of the wild-type allele, making it unlikely that these tumors resulted from homozygous loss of G(s)alpha. CONCLUSIONS: These findings provide in vivo evidence that G(s)alpha pathways inhibit fibroblast and endothelial proliferation and matrix deposition.
INTRODUCTION: The heterotrimeric G protein alpha-subunit G(s)alpha links receptors to stimulation of cAMP/protein kinase A signaling, which inhibits skin fibroblast proliferation and collagen synthesis. We now describe the development of fibrous tumors in mice with heterozygous disruption of the Gnas gene, which encodes G(s)alpha and other gene products. METHODS AND RESULTS: Disruption of Gnas exon 2 on either the maternal or paternal allele (Gnas(E2-/+)) results in fibromas or angiofibromas on the ears, paws and tail beginning at 4 months of age. The tumors were composed of fibroblastic cell proliferation with collagen and elastin deposition and calcification, and seemed to be associated with mechanical skin damage. The presence of calcification was associated with greater amounts of matrix metalloproteinase-2, suggesting an association between calcium deposition and extracellular matrix degradation. Osteoblast-specific markers were absent, consistent with the calcification not being secondary to ossification. Molecular studies showed that the tumors were not associated with deletion of the wild-type allele, making it unlikely that these tumors resulted from homozygous loss of G(s)alpha. CONCLUSIONS: These findings provide in vivo evidence that G(s)alpha pathways inhibit fibroblast and endothelial proliferation and matrix deposition.
Authors: Giovanna Mantovani; Sara Bondioni; Marco Locatelli; Cecilia Pedroni; Andrea G Lania; Emanuele Ferrante; Marcello Filopanti; Paolo Beck-Peccoz; Anna Spada Journal: J Clin Endocrinol Metab Date: 2004-12 Impact factor: 5.958
Authors: L M Graves; K E Bornfeldt; J S Sidhu; G M Argast; E W Raines; R Ross; C C Leslie; E G Krebs Journal: J Biol Chem Date: 1996-01-05 Impact factor: 5.157
Authors: David L Huso; Sarah Edie; Michael A Levine; William Schwindinger; Yingli Wang; Harald Jüppner; Emily L Germain-Lee Journal: PLoS One Date: 2011-06-29 Impact factor: 3.240
Authors: Michael T Cheeseman; Kate Vowell; Tertius A Hough; Lynn Jones; Paras Pathak; Hayley E Tyrer; Michelle Kelly; Roger Cox; Madhuri V Warren; Jo Peters Journal: PLoS One Date: 2012-12-19 Impact factor: 3.240